Simoa® Accelerator Laboratory

Ultra-Sensitive Biomarker Research & Clinical Testing Services


CLIA-Licensed Protein Biomarker Services Powered by Ultrasensitive Simoa® Technologies

Learn more

Empowering Breakthroughs with Simoa Ultra-Sensitivity

The Simoa Accelerator Laboratory provides cutting-edge biomarker research services, leveraging ultra-sensitive Simoa technology for unparalleled precision in protein biomarker detection. Our CLIA-licensed facility supports biopharmaceutical research, clinical sample testing, and custom assay development to accelerate discovery and therapeutic advancements.


    Our Services

    Custom Assay Development & Validation

    We collaborate with research teams to develop and optimize ultra-sensitive biomarker assays tailored to specific study needs.

    • End-to-End Support
      From discovery to drug development, we provide assay design, optimization, and validation.
    • Reagent Selection
      Our partnerships with leading antibody suppliers ensure the best reagent selection for singleplex and multiplex assays.
    • On-Demand Custom Assay Kits
      We manufacture tailored assay kits, supporting in-lab or outsourced use.

    Comprehensive Biomarker Testing

    Our lab offers flexible, scalable biomarker testing solutions to support translational and clinical research:

    • Preclinical & Clinical Sample Testing
      High-throughput analysis for robust, reliable biomarker quantification.
    • GLP & CLIA-Compliant Services
      Ensuring regulatory compliance and data integrity.
    • Multi-Therapeutic Area Expertise
      Supporting neurology, oncology, immunology, infectious disease, and cardiology research.

    LEARN HOW WE CAN ACCELERATE YOUR RESEARCH
    CLIA-Licensed laboratory powered by ultra-sensitive Simoa® HD-X and SP-X technologies
    Quantify proteins far lower than the Level of Quantification (LoQ) of conventional analog immunoassays
    The largest portfolio of Simoa® instruments enables flexible scaling to handle studies of one plate up to thousands of samples
    Full quality-management system infrastructure for end-to-end project management
    Sample testing for longitudinal and prospective clinical studies
    Custom assay development with the expertise of Quanterix Simoa® scientists
    Laboratory performance according to applicable GLP/CLIA/ISO 15189 best practices
    Exploratory biomarker analysis for enhanced PD studies
    Quantify proteins that are BLOQ in typical immunoassay platforms and access baseline analytes in healthy subjects and disease indicators
    Use your proprietary antibodies/reagents or commercially available reagents

    Why Choose the Simoa Accelerator Laboratory?

    Partnering for Success

    Our dedicated scientific team ensures tailored research solutions with a streamlined workflow and expert guidance:

    • Dedicated Scientific Project Management
      Every study is assigned a dedicated project manager to oversee execution and data delivery.
    • Scalability & Efficiency
      Our high-throughput capabilities support studies from small exploratory research to large-scale clinical trials.
    • State-of-the-Art Facility
      Featuring Simoa HD-X, SR-X, and SP-X platforms for femtogram-level biomarker detection.
    Accelerate Your Research with Us

    Join leading pharmaceutical and biotech companies leveraging Simoa technology for groundbreaking discoveries.

    Download Our Brochure

    Simoa® Technology: The Foundation of Ultra-sensitive Custom Assay Development and Biomarker Testing

    The Accelerator Lab is built upon the Simoa® digital immunoassay technology that has revolutionized biomarker detection by giving researchers the ability to examine critical proteins down to femtogram levels. The Simoa® digital health solution enables early disease detection and approaches to treatment.

    Learn More About Simoa Technology

    The Simoa® Accelerator Lab in Action

    Hear from Dr. Havrda about his experience with the Simoa Accelerator Lab in developing a high-performing assay for NLRP3 inflammasome that will empower research into disease progression and therapeutic development for Parkinson’s disease.

    Download Case Study

    “Working closely with the group at Quanterix Accelerator Lab we went from being able to detect our targets in most patients to being able to detect the analytes in everybody, and really stratify the patients based on the degree of expression of these different biomarkers in plasma. The assays allowed us a window to measure the type of inflammation that occurred in Parkinson’s but also provided a window to discovery of new drugs that target inflammation in Parkinson’s.”

    Matthew Havrda, Associate Professor, Molecular and Systems Biology, Geisel School of Medicine at Dartmouth

    Start Working With our Accelerator Team Today

    Request a quote for Accelerator laboratory services, or submit a sample shipment request through our Customer Portal by creating a free account.

    See Publications Featuring Accelerator Lab Projects

    View list

    Ready to take your biomarker research to the next level?

    request a quote